|

Efgartigimod IV Clinical Trials

3 actively recruiting trials across 2 locations

Pipeline

Phase 2: 1Phase 2/3: 1

Top Sponsors

  • argenx3

Indications

  • Generalized Myasthenia Gravis3
  • Cancer3
  • gMG2
  • MG2
  • AChR-Ab Seropositive Generalized Myasthenia Gravis2

Carlsbad, California2 trials

ADAPT Forward - Master Protocol of a Platform Study to Evaluate the Safety and Efficacy of Multiple Regimens in Participants With Myasthenia Gravis

Profound Research LLC - Carlsbad

ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy to Efgartigimod IV in Participants With AChR-Ab Seropositive Generalized Myasthenia Gravis With a Partial Clinical Response to Efgartigimod

Profound Research LLC - Carlsbad

Phase 2

Chicago, Illinois1 trial

Evaluating the Pharmacokinetics, Pharmacodynamics, and Safety of Efgartigimod Administered Intravenously in Children With Generalized Myasthenia Gravis

Ann and Robert H Lurie Children's Hospital of Chicago - Main Hospital

Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.